Literature DB >> 977527

Kinetic studies on the combination rifampicin-trimethoprim in man. I. Absorption and urinary excretion after administration to healthy volunteers of single doses of the two compounds alone and in combination, and of the combination over a period of 1 week.

G Acocella, R Scotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 977527     DOI： 10.1093/jac/2.3.271

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae.

Authors:  Maria Loose; Isabell Link; Kurt G Naber; Florian M E Wagenlehner
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Evidence that rifampicin can be used safely for non-tuberculous diseases.

Authors:  G Acocella; W Brumfitt; J M Hamilton-Miller
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

Review 3.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

4.  Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.

Authors:  G E Stein; D Gurwith; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

5.  Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.

Authors:  A M Bourgault; K R Forward; A R Ronald; G K Harding; M Thomson; G Grey
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

6.  Interaction between chloramphenicol and acetaminophen.

Authors:  J S Spika; D J Davis; S R Martin; K Beharry; J Rex; J V Aranda
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

7.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.